In house synthesized novel distyryl-BODIPY dye and polymer assembly as deep-red emitting probe for protamine detection.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 27 05 2023
revised: 02 07 2023
accepted: 03 07 2023
medline: 2 8 2023
pubmed: 14 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

In this contribution, we designed and synthesized a deep-red emitting distyryl-BODIPY dye (dye 3) which is non-fluorescent in aqueous solution due to the formation of non-emissive aggregates. However, in presence of an amphiphilic polymer (polystyrene sulfonate, PSS), the aggregated dye molecules de-aggregate and form dye 3-PSS complex, which significantly modulates the optical features of the bound dye. Interestingly, the dye 3-PSS complex shows turn-on fluorescence response in deep-red region in presence of protamine (Pr) due to the formation of dye 3-PSS-Pr ternary complex. Such enhancement follows a linear trend in the dynamic range of 0-8.75 μM of Pr which has been utilized to determine Pr with limit of detection (LOD) of 15.04(±0.5) nM in phosphate buffer. Furthermore, excellent selectivity of the dye 3-PSS system towards Pr allows us to determine Pr even in complex biological matrix like 1% human serum. Thus, dye 3-PSS system can be applied as a very effective tool for the detection and quantification of Pr in deep-red region, overcoming several limitations encountered with the probes in the shorter wavelength region. This is the first report on BODIPY dye based supramolecular assembly for sensing and quantification of protamine.

Identifiants

pubmed: 37442005
pii: S0039-9140(23)00666-5
doi: 10.1016/j.talanta.2023.124915
pii:
doi:

Substances chimiques

Fluorescent Dyes 0
Protamines 0
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 0
Boron Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124915

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest There is no competing conflict of interest to be declared.

Auteurs

Sudip Gorai (S)

Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai, 400085, India; Homi Bhabha National Institute, Anushakti Nagar, Mumbai, 400094, India.

Soumyaditya Mula (S)

Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai, 400085, India; Homi Bhabha National Institute, Anushakti Nagar, Mumbai, 400094, India. Electronic address: smula@barc.gov.in.

Padma Nilaya Jonnalgadda (PN)

Homi Bhabha National Institute, Anushakti Nagar, Mumbai, 400094, India; Laser and Plasma Technology Division, Bhabha Atomic Research Centre, Mumbai, 400085, India.

Birija S Patro (BS)

Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai, 400085, India; Homi Bhabha National Institute, Anushakti Nagar, Mumbai, 400094, India.

Goutam Chakraborty (G)

Laser and Plasma Technology Division, Bhabha Atomic Research Centre, Mumbai, 400085, India. Electronic address: gchak@barc.gov.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH